HilleVax, Inc., (HLVX): Price and Financial Metrics
HLVX Price/Volume Stats
| Current price | $1.99 | 52-week high | $15.60 |
| Prev. close | $1.96 | 52-week low | $1.34 |
| Day low | $1.93 | Volume | 101,200 |
| Day high | $2.02 | Avg. volume | 216,079 |
| 50-day MA | $1.79 | Dividend yield | N/A |
| 200-day MA | $1.84 | Market Cap | 99.78M |
HLVX Stock Price Chart Interactive Chart >
HilleVax, Inc., (HLVX) Company Bio
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.
HLVX Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
HLVX Price Returns
| 1-mo | 4.19% |
| 3-mo | 8.15% |
| 6-mo | -3.40% |
| 1-year | -85.30% |
| 3-year | -78.46% |
| 5-year | N/A |
| YTD | -3.86% |
| 2024 | -87.10% |
| 2023 | -4.06% |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |